MK-7075 (Miransertib) in Proteus Syndrome
Clinical trial NCT04316546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04316546
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2026-06-25
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.